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Novelty statement
• This is the largest study in the UK to investigate associations between ethnicity, deprivation and glycaemic-control using a large nationally representative sample of children with type 1 diabetes, from all major ethnic groups.
• Black and mixed ethnicity children had poorest glycaemic-control. Greater deprivation was associated with worse glycaemic-control in all ethnicities.
• Ethnicity, deprivation and treatment regimen were independentely associated with glycaemic control. Results suggest that increasing insulin pump use in ethnic minority and more deprived children will help these groups achieve better glycaemic control.
Introduction
Inequalities in Type 1 Diabetes (T1D) treatment and disparities in glycaemic control in children and young people are well documented and are associated with severe short-term (hypoglycaemia and diabetic ketoacidosis) and long-term complications (nephropathy, retinopathy, neuropathy and cardiovascular disease) (1) . Additionally, poor glycaemic control impacts adversely on family dynamics and tracks from childhood into adulthood increasing the lifetime risk of vascular complications and significantly reducing life expectancy (2, 3) . Despite robust evidence showing the efficacy of intensive insulin regimens in improving outcomes, inequalities in treatments and outcomes related to T1D remain strong even in countries with tax-funded universal healthcare systems (4) (5) (6) (7) (8) .
Research from outside the UK shows that ethnic minority children and those from lower Socioeconomic Status (SES) have consistently poorer glycaemic control (4, 6, 7, (9) (10) (11) . Studies on health inequalities related to T1D treatment and glycaemic control in England and Wales have been conducted on smaller study samples often restricted to particular clinics or regions (4, (12) (13) (14) . The role of ethnicity has not been comprehensively studied often due to low numbers of ethnic minorities. Some studies also showed contradictory results (14) . Previously observed differences in glycaemic control between ethnic groups could be a reflection of greater deprivation in ethnic minorities and/or poorer access to intensive treatment regimens. Additionally, most of the evidence for inequalities in T1D health care processes, treatment and outcomes originate from North America, northern Europe and Australasia, where ethnic groupings and/or healthcare differ to the UK (5, 6, (15) (16) (17) (18) . Thus there is a strong need to investigate social and ethnic differences in glycaemic control in children in England and Wales.
The main aim of this study is to investigate whether ethnicity and SES are associated with glycaemic control in children with T1D using a nationwide population-based register that includes almost all T1D people under nineteen years of age representing all major ethnic groups with reliable measures of ethnicity and deprivation in England and Wales. We wanted to identify ethnic minority groups with the worst glycaemic control. Additionally, we wanted to investigate if ethnic differences in glycaemic control are independent of SES and treatment regimen and if ethnicity interacts with SES in its association with glycemic control. Differences if any in glycaemic control between white and ethnic minority children that appear to be mediated by modifiable factors such as treatment regimen will provide opportunities for targeted interventions. For this study the main predictors of diabetes control were ethnicity and SES. Participants (or their parents)
Methods

Data
were asked to self-identify their ethnicity when they visited a clinic. They were given the option to choose one of the fifteen categories as recommended by the Information Standards Board (ISB) for Health and Social Care. Participants were also given the option to decline identifying their ethnicity. For the purpose of this study, the fifteen ethnic categories were collapsed into six broad groups: white, Asian, black, mixed, other and 'not stated' (those who declined). with each area comprising 1500 individuals on average. IMD rank scores were grouped into quintiles for analysis, with the first and fifth quintiles corresponding to the least and most deprived respectively.
Of the 19,122 children eligible to be included, 24 lacked data on gender, 360 on SES, and 260 on HbA1c. This left 18,478 children with T1D (96.6% of the eligible sample) with data on age, gender, diabetes duration, ethnicity and SES and were included in the main analysis to assess associations between ethnicity, SES and glycaemic control. A smaller sample of 13,962 participants with data on treatment regimen and all other covariates was included in a sub-analysis to assess the effects of treatment regimen on associations between ethnicity, SES and glycaemic control. We investigated whether the 4,516 excluded participants due to missing data on treatment regimen differed from the 13,962 children included in the sub-analysis.
We compared the two groups on all covariates using univariable linear regression or Chi square tests for differences of proportions for continuous and categorical variables respectively.
Statistical analysis
Continuous variables are presented as mean values with standard deviations and categorical variables as frequencies. Associations between ethnicity and SES and other covariates were analysed using univariable linear regression or Chi square tests for differences of proportions for continuous and categorical variables respectively.
Multivariable linear regression models were fitted with mean HbA1c as the principle outcome and ethnicity or SES as the primary predictor (Models 1 and 2 respectively) to assess associations. Model 3 included both predictors to assess mutually adjusted associations of ethnicity and SES.. All models were adjusted for child's age during the audit year (years), gender and diabetes duration (years). For linear regression analyses, assumptions of linearity for continuous variables and constant variance of the standardized residuals were assessed by plotting the residuals against the fitted values. Model fit of the three models was compared using R 2 which represents the proportion of variation in HbA1c explained by the model.
Model 1, with SES as the main predictor, was then run stratified by ethnicity to assess whether the association between SES and HbA1c were similar across all ethnic groups. Interactions between ethnicity and SES were tested using likelihood ratios tests. Robust standard errors allowing for clustering of children within clinics were used for all linear regression models.
A sub-analysis was performed using adjustments for the same covariates as in Model 3 above but restricted to the smaller study sample of 13,962 children with information on treatment regimen to assess if the latter could explain differences in glycaemic control by ethnicity or SES.
Further analysis was performed for the association between ethnicity, SES and HbA1c (using the same adjustments for covariates as described above) by fitting linear multilevel models which take into account random effects that vary across clinics. As multilevel modelling yielded the same results as multivariable linear regression, we present results from the former in Supplemental Table 1 . All statistical analyses were conducted using STATA 13 (College Station, TX, USA).
The study protocol was reviewed by University College London (UCL) Research Ethics Committee which decided that ethics approval was not required. The NPDA has section 251 approval to collect patient identifiable information for the purpose of audit. For this study all participants were pseudonomised making them unidentifiable. The study is registered with the R&D office, Institute of Child Health, UCL, (Project number 14PP08).
Results
The mean age of the study sample was 12.76 years (range 1.3 to 19.0 years). Age at first visit in the audit year and age at diagnosis differed by ethnicity. On average, ethnic minority children were diagnosed younger than white children but differences were small and clinically not relevant. There was no statistically significant difference in diabetes duration between ethnic groups. In comparison to children of white ethnicity, children of all other ethnicities had higher mean HbA1c levels with highest levels observed in black and mixed ethnicity groups (80mmol/mol [9.5%] and 79mmol/mol [9.4%] respectively, Table 1 ). In comparison to the white group, all ethnicities had higher proportions of children in the most deprived socioeconomic group (IMD quintile 5). More than half of all black children were in the most deprived quintile (52.6%, Table 1 ). Significant differences were observed in proportions of children on insulin pump therapy by ethnicity. For those with information on pump use, the white group had the largest proportion on insulin pump therapy (20.3%), whereas the black and 'not stated' groups had the lowest proportions (5.5% and 5.0% respectively).
On average age at first visit in the audit year was slightly lower in the most deprived groups (quintiles 4 and 5) compared to the least deprived group (quintile 1), however differences were clinically not relevant.
There were no differences in diabetes duration across the quintiles of deprivation. We observed a strong positive association between deprivation and mean HbA1c levels (the most deprived quintile had on average 7mmol/mol [2.8%] higher HbA1c compared to the least deprived quintile (Table 2) ). Similarly, the proportions of children on insulin pump therapy decreased with increasing deprivation (13.2% in the most deprived group were on insulin pump therapy compared to 21.2% in least deprived group, Table 2 ). Table 3 ). SES was significantly associated with glycaemic control with a strong apparent dose-effect across quintiles. In the regression model with SES only, being in quintiles 2 to 5 was associated with higher mean HbA1c, with the most deprived group (quintile 5) having the highest HbA1c (on average 7mmol/mol [2.8%] higher HbA1c compared to the least deprived group, Model 2, Table 3 ). However, after controlling for SES, (i.e. the model which included both ethnicity and SES, Model 3, Table 3 ), the estimates for all ethnic groups were attenuated considerably and were no longer significant for the 'other' group. In contrast, the estimates for deprivation quintiles were only marginally attenuated on adjustment for ethnicity (Model 3, Table 3 ).
The association between SES and glycaemic control was similar across ethnic groups in stratified analysis, i.e. having a lower SES was associated with higher mean HbA1c irrespective of ethnicity. However, being in the lowest SES groups (quintiles 4 and 5) and of Asian, mixed, other and 'not stated' ethnicity was associated with significantly higher mean HbA1c compared to being in the lowest SES groups and having white ethnicity (Table 4 (Table 4 ). The interaction test between ethnicity and SES was statistically significant (P=0.006).
In models restricted to those with information on insulin pump therapy (N=13,962), both ethnicity and SES remained independently associated with HbA1c levels with a pattern very similar to that observed in regression models with the entire study population. However, on adjustment for pump therapy being in the Asian group or in deprivation quintile 2 was no longer significantly associated with higher HbA1c (Model4 , Table 5 ). Adjustment for pump therapy marginally attenuated the estimates for the black and the more deprived groups (quintiles 3 to 5). On average children on insulin pump therapy had lower mean HbA1c compared to those on other therapies (-5 [-2.6%], -6.16 -3.67), Model 4, Table 5 .
Discussion
Results from this study indicate that minority ethnicity, deprivation and access to insulin pump therapy are each independently associated with poorer glycaemic control in this large national sample. Black and mixed ethnicity children had the poorest glycaemic control. Low SES was associated with worse glycaemic control in all ethnicities. Whilst the estimates of ethnicity, SES and treatment regimen are smaller in the mutually adjusted models, they remain for black and mixed children and are attenuated for Asian children. This suggests that for Asians, deprivation and lack of access to pumps maybe the main way in which ethnic group membership affects glycaemic control. However, the observed poorer glycaemic control in black and mixed children is probably a result of factors not accounted for, such as cultural/lifestyle and/or those relating to healthcare access above and beyond insulin pump use.
Few UK studies have examined the combined effect of ethnicity and SES on glycaemic control in children.
These studies were smaller in size, restricted to fewer ethnicities, small geographical regions and clinics (4, 12, 13) . Due to small sample sizes, studies also combined all ethnic minorities into one group for comparisons with the white group (12) . Consistent with our findings, previous UK studies found that children of African or black ethnicity and those with greater deprivation (lower SES) had the highest mean HbA1c levels or worse glycaemic control (4, 13). However, ours is the first to show the inverse association between SES and glycaemic control is present with a dose-effect in most ethnic groups in England and
Wales.
This is the largest study to date in the UK to have analysed ethnic and SES differences in glycaemic control in children with T1D. It is the first study to analyse differences in glycaemic control in all six major ethnic groups corresponding to official standard ethnicity classifications. Additionally, ethnicity is self-identified which is considered the 'gold standard' in studies on ethnicity and health (22) . The IMD scores have been shown to be associated with several health outcomes is previous studies and is considered to be the standard benchmark for UK governmental health and social policy (23) .
The NPDA data is collected annually by participating paediatric diabetes clinics. Each clinic submits data on all participants under their care to a centralised database which helps minimize selection bias. Although the NPDA cannot verify whether 100% of children with diabetes in England and Wales are included in the audit, it is estimated to represent in excess of 95% of cases and is nationally representative.
Previous studies showed that T1D children from single parent households have consistently worse glycaemic control compared to those living with both parents, a factor we were unable to account for in our analyses (24, 25) . The NPDA does not collect data on physical activity and diet which might explain the observed differences. We had significant missing data on treatment regimen. However, as sensitivity analyses revealed, we believe our results from the sub-analysis on treatment regimen can be generalized to the entire study population.
The category 'Not Stated' is used when an individual has been asked for but declined to provide information on their ethnicity. However, the NPDA cannot verify that this is the case and it may contain individuals where the ethnicity is unknown. This group appeared to be similar to the white group when compared on mean HbA1c, age at diagnosis, age at visit, proportion of boys and SES. We observed no significant differences between 'Not stated' and white groups in regression models indicating that the former is composed of mostly white children. However, in the stratified analysis, children with 'not stated' ethnicity and belonging to the lowest SES groups had much higher mean HbA1c compared to white children of the same SES groups (10mmol/mol [3.1%] vs 6mmol/mol [2.7%] respectively). In all likelihood, this group is a heterogeneous mix of children belonging to different ethnicities.
The observed independent association between ethnicity and glycaemic control in this study population could be attributed to cultural and lifestyle differences between ethnicities such as diet and physical activity which impact on glycaemic control (26) . As previously reported, certain ethnic groups might favour a particular treatment regimen and older participants might be more reluctant to change to new therapies (4) . Cultural barriers might lead to less effective communication between healthcare providers and families of ethnic minority diabetic children, especially for those that do not have English as their first language.
Another explanation is the evident lower insulin pump use among ethnic minorities and lower SES groups (27) . However, accounting for pump use only marginally attenuated the observed ethnicity/SES estimates.
Observed differences could also reflect in part, biological differences between ethnic groups such as that related to haemoglobin glycation (28, 29) . Also higher cumulative stress in ethnic minorities might lead to alterations in allostatic load (physiologic response to chronic exposure to stress), which in turn influences cortisol secretion (30) . This can lead to differences in glucose regulation (31) .
The National Health Service provides free medical care in the country and thus direct costs of T1D treatment should have no bearing on patient's families and, theoretically, income should not be an impediment for access to treatment. For lower SES families, cost of transport to and from clinics is reimbursed. However, the relative economic impact of the carer taking time off work is likely to be greater in low income families and such losses are not reimbursed. However, the strong differences observed in glycaemic control between the lowest and highest SES groups despite free access to healthcare points to possible cultural differences in how treatment methods are managed at home or by their clinical team and/or to barriers in access to better treatments. Additionally, it appears that SES is a stronger determinant of glycaemic control than ethnicity as it was consistently evident in all ethnicities.
In order to improve glycaemic control, better consideration of the needs of all ethnic groups and those belonging to lower SES need to be taken into account. This could involve strengthening the implementation of insulin pump therapy, reviewing how healthcare professionals interact with patients and their families, and a deeper understanding of cultural difference in attitudes to disease management. Further studies are needed to better understand underlying mechanisms which could explain poorer glycaemic control in black and mixed ethnicity children. 
